Biotech innovator Liquidia, specializing in pulmonary therapies, reported a notable insider sale amid continued growth in its ...

Wearable device data may help detect and track idiopathic pulmonary arterial hypertension, a rare lung disease, a study ...

SAN FRANCISCO, April 17, 2026 /PRNewswire/ -- A securities class action lawsuit has been filed against Gossamer Bio, Inc. (NASDAQ: GOSS) and an executive, seeking to represent investors who purchased ...

GSK has completed its 950 million dollar acquisition of 35Pharma, adding HS235, a promising pulmonary hypertension therapy, ...

GSK completes acquisition of Canada-based, clinical-stage biopharma company, 35Pharma Inc: London, UK Thursday, April 16, 2026, 09:00 Hrs [IST] GSK plc announced the completion of ...

Approval was supported by the phase 3 LANDI-PED study, which demonstrated significant heart rate reduction and conversion to normal sinus rhythm in pediatric patients.

Allrock Bio has dosed the first participants in a small clinical trial testing ROC-101 as an add-on treatment for pulmonary ...

(Alliance News) - GSK PLC on Wednesday said it has completed the acquisition of Canada-based clinical stage biopharmaceutical ...

Three cancer drugs and a new eczema medication are among the pharmaceuticals that a medical body has accepted for use by NHS ...

Scottish Medicines Consortium approves new NHS Scotland drugs for lung cancer, leukaemia, cervical cancer, pulmonary ...